Receiving a letter from the Food and Drug Administration (FDA) can be a pivotal moment for any company in highly regulated industries such as cannabis, CBD, and nutraceuticals. Your response and subsequent actions are crucial, whether it's a Form 483 observation or a Warning Letter. This article provides essential tips on effectively addressing FDA concerns […]